Harriet de Wit
Director/Miembro de la Junta en PHARMALA BIOTECH HOLDINGS INC. .
Fortuna: 15 800 $ al 30/04/2024
Perfil
Harriet de Wit is currently a Director at Pharmala Biotech Holdings, Inc. and Pharmala Biotech, Inc. She is also a Professor at The University of Chicago.
She received her doctorate degree from Concordia University in 1981 and her undergraduate degree from the University of Calgary.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 27/02/2024 | 100 000 ( 0.12% ) | 15 800 $ | 30/04/2024 |
Cargos activos de Harriet de Wit
| Empresas | Cargo | Inicio |
|---|---|---|
| PHARMALA BIOTECH HOLDINGS INC. | Director/Miembro de la Junta | 21/03/2021 |
| The University of Chicago | Corporate Officer/Principal | - |
Pharmala Biotech, Inc.
 Pharmala Biotech, Inc. BiotechnologyHealth Technology Part of Pharmala Biotech Holdings, Inc., Pharmala Biotech, Inc. is a Canadian biotechnology company that manufactures and sells MDMA and MDXX class molecules. The company is based in Toronto, Canada. The company was founded by Nicholas Kadysh. Nicholas Kadysh has been the CEO since incorporation. | Director/Miembro de la Junta | - |
Formación de Harriet de Wit.
| University of Calgary | Undergraduate Degree |
| Concordia University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| PHARMALA BIOTECH HOLDINGS INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Pharmala Biotech, Inc.
Pharmala Biotech, Inc. BiotechnologyHealth Technology Part of Pharmala Biotech Holdings, Inc., Pharmala Biotech, Inc. is a Canadian biotechnology company that manufactures and sells MDMA and MDXX class molecules. The company is based in Toronto, Canada. The company was founded by Nicholas Kadysh. Nicholas Kadysh has been the CEO since incorporation. | Health Technology |
- Bolsa de valores
- Insiders
- Harriet de Wit